Incretins Prevent the Development of Atherosclerosis in Apolipo-protein E-Null Mice

被引：0
作者：
Nagashima, Toshiharu
Watanabe, Takuya
Nohtomi, Kyoko
Miyazaki, Akira
Hirano, Tsutomu
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A75 / A76
页数：2
相关论文
共 50 条
  • [21] MACROPHAGE-SPECIFIC EXPRESSION OF HUMAN APOLIPOPROTEIN-E REDUCES ATHEROSCLEROSIS IN HYPERCHOLESTEROLEMIC APOLIPOPROTEIN E-NULL MICE
    BELLOSTA, S
    MAHLEY, RW
    SANAN, DA
    MURATA, J
    NEWLAND, DL
    TAYLOR, JM
    PITAS, RE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) : 2170 - 2179
  • [22] Loss of urokinase plasminogen activator expression in macrophages retards aortic atherosclerosis in apolipoprotein e-null mice
    Krishnan, Ranjini M.
    Wu, Alyssa
    Slezicki, Katherine I.
    Buben, Amelia
    Kremen, Michal
    Dichek, Helen L.
    Dichek, David A.
    [J]. CIRCULATION, 2006, 114 (18) : 334 - 335
  • [23] An oral ApoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice
    Navab, M
    Anantharamaiah, GM
    Reddy, ST
    Van Lenten, BJ
    Wagner, AC
    Hama, S
    Hough, G
    Bachini, E
    Garber, DW
    Mishra, VK
    Palgunachari, MN
    Fogelman, AM
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (09) : 1932 - 1937
  • [24] Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice
    Li, XJ
    Chyu, KY
    Neto, JRF
    Yano, J
    Nathwani, N
    Ferreira, C
    Dimayuga, PC
    Cercek, B
    Kaul, S
    Shah, PK
    [J]. CIRCULATION, 2004, 110 (12) : 1701 - 1705
  • [25] Plasma insulin levels predict the development of atherosclerosis when IRS2 deficiency is combined with severe hypercholesterolemia in apolipoprotein E-null mice
    Gonzalez-Navarro, Herminia
    Vila-Caballer, Marian
    Pastor, Maria F.
    Vinue, Angela
    White, Morris F.
    Burks, Deborah
    Andres, Vicente
    [J]. FRONTIERS IN BIOSCIENCE, 2007, 12 : 2291 - 2298
  • [26] A Dipeptidyl Peptidase-4 Inhibitor but not Incretins Suppresses Abdominal Aortic Aneurysms in Angiotensin II-Infused Apolipoprotein E-Null Mice
    Kohashi, Kyoko
    Hiromura, Munenori
    Mori, Yusaku
    Terasaki, Michishige
    Watanabe, Takuya
    Kushima, Hideki
    Shinmura, Kyoko
    Tomoyasu, Masako
    Nagashima, Masaharu
    Hirano, Tsutomu
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (04) : 441 - 454
  • [27] 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice
    Wool, Geoffrey D.
    Cabana, Veneracion G.
    Lukens, John
    Shaw, Peter X.
    Binder, Christoph J.
    Witztum, Joseph L.
    Reardon, Catherine A.
    Getz, Godfrey S.
    [J]. FASEB JOURNAL, 2011, 25 (01) : 290 - 300
  • [28] Efavirenz treatment causes arterial stiffening in apolipoprotein E-null mice
    Caulk, Alexander W.
    Soler, Jose
    Platt, Manu O.
    Gleason, Rudolph L., Jr.
    [J]. JOURNAL OF BIOMECHANICS, 2015, 48 (10) : 2176 - 2180
  • [29] Hyperinsulinemia Does Not Change Atherosclerosis Development in Apolipoprotein E Null Mice
    Rask-Madsen, Christian
    Buonomo, Erica
    Li, Qian
    Park, Kyoungmin
    Clermont, Allen C.
    Yerokun, Oluwatobi
    Rekhter, Mark
    King, George L.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (05) : 1124 - +
  • [30] Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice
    Chyu, KY
    Babbidge, SM
    Zhao, XN
    Dandillaya, R
    Rietveld, AG
    Yano, J
    Dimayuga, P
    Cercek, B
    Shah, PK
    [J]. CIRCULATION, 2004, 109 (20) : 2448 - 2453
12345